BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26151848)

  • 21. Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus.
    Srikumar BN; Naidu PS; Kalidindi N; Paschapur M; Adepu B; Subramani S; Nagar J; Srivastava R; Sreedhara MV; Prasad DS; Das ML; Louis JV; Kuchibhotla VK; Dudhgaonkar S; Pieschl RL; Li YW; Bristow LJ; Ramarao M; Vikramadithyan RK
    J Psychopharmacol; 2019 Jan; 33(1):25-36. PubMed ID: 30484737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus.
    Tomita M; Holman BJ; Williams LS; Pang KC; Santoro TJ
    J Neurosci Res; 2001 Apr; 64(1):26-33. PubMed ID: 11276048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
    Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
    Front Immunol; 2020; 11():573677. PubMed ID: 33042154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus.
    Stock AD; Der E; Gelb S; Huang M; Weidenheim K; Ben-Zvi A; Putterman C
    JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
    Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
    Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
    Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment of MRL mice is related to NMDA receptor-mediated inflammatory response and production of adhesion molecules in MRL/lpr mice-derived micro-vascular endothelial cells.
    Guan X; Wang J
    Folia Neuropathol; 2023; 61(1):25-36. PubMed ID: 37114958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
    Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
    Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic CD4
    Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
    J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
    Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
    Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.
    Qiao X; Wang H; Lu L; Chen J; Cheng Q; Guo M; Hou Y; Dou H
    J Neuroimmunol; 2021 Aug; 357():577620. PubMed ID: 34062352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
    Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
    Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.
    Souza LC; Jesse CR; de Gomes MG; Del Fabbro L; Goes ATR; Donato F; Boeira SP
    Neurochem Res; 2017 Oct; 42(10):2982-2995. PubMed ID: 28631232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.